General Electric Company (NYSE: GE) is still doing M&A deals. The company has had its checkbook out lately and announcing ventures, and this morning came word from GE Healthcare that it was acquiring Clarient,…
The elderly are different than you and me, and it is not just because they are over 65. The habits of older Americans are, in many cases, much different from younger Americans. Older Americans…
A study by medical industry research firm Wolters Kluwer Pharma Solutions reported on in The Wall Street Journal, says that people who order prescription drugs often do not pick them up at pharmacies because…
The world of biotech and biohealth is seeing a flurry of news today. This is bringing on many winners and losers in the sector. We are tracking the news and the moves in Alexza…
The Sanofi-Aventis (NYSE: SNY) acquisition attempt of Genzyme Corp. (NASDAQ: GENZ) is taking a turn in a strange direction. The company is holding out for more than the $69.00 cash offer on the table,…
Wal-Mart Stores Inc. (NYSE: WMT) has just pumped up the pressure on its competitors in the pharmacy business. The retailing giant has announced a joint program with Humana Inc. (NYSE: HUM) to offer a…
The proposed merger and acquisition of Genzyme Corporation (NASDAQ: GENZ) by Sanofi-Aventis (NYSE: SNY) is about to get interesting. There is a building collective thought that a higher bid price than $69.00 in cash…
Bristol-Myers Squibb (NYSE: BMY) will cut nearly 1,000 workers. That is on top of large rounds of firings in 2007 and 2008. The company gave an odd reason for the action.”The ultimate goal of…
Genzyme (NASDAQ: GENZ), the target of a buyout offer from Sanofi-Aventis, began to lay-off almost 10% of its workforce today. The company would not say exactly what the size of the cuts would be.…
Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there has been on a single day in months and months. The news is not…
Family health premiums rose 3% to $13,770. this year. The number seems modest but it is not for those who are insured. According to new data from the Kaiser Family Foundation 2010 Employer Health…
There are many issues to watch in the coming week for this weekend’s edition of THE UNUSUAL SUSPECTS. We have some earnings on deck and some unfinished business from last week, but there are…
Genzyme Corporation (NASDAQ: GENZ) still has an incredible merger ‘deal premium’ associated with it over a pending Sanofi-Aventis (NYSE: SNY) buyout. Genzyme’s troubles have left it vulnerable to a deal for a while now,…
Health care costs for treating obesity-related illness are as high as $149 billion per year, according to a report released by the National Center for Chronic Disease Prevention and Health Promotion, a division of…
This has been a year to forget for Johnson & Johnson (NYSE: JNJ). Unfortunately for shareholders, the company’s board appears ill-equipped to handle two serious problems that may tarnish the company’s reputation. In January,…